Fortress Ebitda from 2010 to 2024

FBIO Stock  USD 2.18  0.01  0.46%   
Fortress Biotech EBITDA yearly trend continues to be very stable with very little volatility. EBITDA is likely to grow to about -127 M this year. During the period from 2010 to 2024, Fortress Biotech EBITDA quarterly data regression pattern had range of 181 M and standard deviation of  53,485,190. View All Fundamentals
 
EBITDA  
First Reported
2010-09-30
Previous Quarter
-26.1 M
Current Value
-21.1 M
Quarterly Volatility
15.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Fortress Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fortress Biotech's main balance sheet or income statement drivers, such as Interest Expense of 6.5 M, Selling General Administrative of 104.7 M or Research Development of 59.7 M, as well as many indicators such as Price To Sales Ratio of 0.27, Dividend Yield of 0.38 or PTB Ratio of 1.03. Fortress financial statements analysis is a perfect complement when working with Fortress Biotech Valuation or Volatility modules.
  
Check out the analysis of Fortress Biotech Correlation against competitors.
To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.

Latest Fortress Biotech's Ebitda Growth Pattern

Below is the plot of the Ebitda of Fortress Biotech over the last few years. It is Fortress Biotech's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fortress Biotech's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Fortress Ebitda Regression Statistics

Arithmetic Mean(82,657,257)
Coefficient Of Variation(64.71)
Mean Deviation45,172,640
Median(87,820,000)
Standard Deviation53,485,190
Sample Variance2860.7T
Range181M
R-Value(0.91)
Mean Square Error556.7T
R-Squared0.82
Slope(10,825,257)
Total Sum of Squares40049.3T

Fortress Ebitda History

2024-127 M
2023-133.6 M
2022-190.5 M
2021-142.3 M
2020-87.8 M
2019-103.6 M
2018-116.8 M

About Fortress Biotech Financial Statements

Fortress Biotech investors utilize fundamental indicators, such as Ebitda, to predict how Fortress Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
EBITDA-133.6 M-127 M

Pair Trading with Fortress Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fortress Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Fortress Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fortress Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fortress Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fortress Biotech to buy it.
The correlation of Fortress Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fortress Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fortress Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fortress Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Fortress Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fortress Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fortress Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fortress Biotech Stock:
Check out the analysis of Fortress Biotech Correlation against competitors.
To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(27.73)
Revenue Per Share
6.15
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.36)
Return On Equity
(17.40)
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.